Lv1
20 积分 2024-06-18 加入
Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in breast cancer that can be reversed by PI3K/mTOR inhibitors
21天前
已完结
Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study
21天前
已完结
Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer
3个月前
已完结
Principles and Problems of Exosome Isolation from Biological Fluids
6个月前
已完结
Isolation and Characterization of Exosomes Derived from Mouse Spleen Tissues
6个月前
已完结
Dietary fructose enhances tumour growth indirectly via interorgan lipid transfer
9个月前
已完结
Chemotherapy (CT) and hormonotherapy (HT) as neoadjuvant treatment in luminal breast cancer patients: results from the GEICAM/2006-03, a multicenter, randomized, phase-II study
1年前
已完结
Neoadjuvant Endocrine Therapy in Clinical Practice
1年前
已完结
Concurrent chemo-endocrine treatment for early hormone-positive breast cancer: a no-go???
1年前
已完结
Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis
1年前
已完结
皖公网安备34019202002308
